Lifecore Biomedical, Inc.
LFCR
$6.41
$0.071.11%
NASDAQ
| 02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | 02/25/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.65M | -14.25M | 6.54M | 12.01M | -20.19M |
| Total Depreciation and Amortization | 7.87M | 7.80M | 7.52M | 7.69M | 8.11M |
| Total Amortization of Deferred Charges | 500.00K | 500.00K | 500.00K | 500.00K | -- |
| Total Other Non-Cash Items | 38.49M | 7.84M | -14.76M | -16.43M | 1.79M |
| Change in Net Operating Assets | 883.00K | -1.41M | 8.08M | -3.59M | -936.00K |
| Cash from Operations | 3.09M | 469.00K | 7.87M | 181.00K | -10.72M |
| Capital Expenditure | -13.96M | -14.87M | -16.66M | -18.32M | -22.86M |
| Sale of Property, Plant, and Equipment | 7.00M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 1.01M |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.96M | -14.87M | -16.66M | -18.32M | -21.85M |
| Total Debt Issued | 146.48M | 149.52M | 149.22M | 149.59M | 181.19M |
| Total Debt Repaid | -164.83M | -158.83M | -147.63M | -147.42M | -151.61M |
| Issuance of Common Stock | 23.86M | 23.84M | 1.00K | 724.00K | 724.00K |
| Repurchase of Common Stock | -1.16M | -1.07M | -696.00K | -152.00K | -99.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.86M | 7.17M | 4.77M | 4.77M | 2.50M |
| Cash from Financing | 6.21M | 20.63M | 5.67M | 7.51M | 32.69M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.34M | 6.23M | -3.12M | -10.63M | 123.00K |